Literature DB >> 6780328

Clinical evaluation of measuring glycosylated hemoglobin levels for assessing the long-term blood glucose control in diabetics.

M Inada, M Oishi, M Nishikawa, S Kurata, H Imura.   

Abstract

The glycosylated hemoglobin levels were determined in the hemolysates obtained from 14 normal subjects and 67 patients with adult-onset diabetes mellitus, using the column chromatographic procedure of Trivelli et al. The levels of hemoglobin A1a+b (HbA1a+b) and HbA1c and the sum of HbA1a+b and HbA1c (HbA1a+b+HbA1c) in normal subjects averaged 2.3 +/- 0.4 (SD)%, 5.3 +/- 0.8% and 7.6 +/- 1.0%, respectively. Although a slight increase in HbA1a+b was found in patients with diabetes mellitus (mean +/- SD=2.8 +/- 0.7%), it was not significantly different from that in normal subjects. Despite the wide range, HbA1c and HbA1a+b+HbA1c were significantly increased in patients with diabetes mellitus (6.9 +/- 1.8% for HbA1c, p < 0.01 and 9.7 +/- 2.2% for HbA1a+b+HbA1c, p < 0.01). A significant correlation existed between the glycosylated hemoglobins and plasma glucose levels determined in the same blood (r = +0.57, p < 0.001). Moreover, the glycosylated hemoglobin levels correlated significantly with the average glucose levels for several months preceding the hemoglobin measurements. In particular, a striking correlation was evident in the plots of HbA1a+b+HbA1c against the mean plasma glucose for 3 months prior to the hemoglobin measurements, which had a correlation coefficient of 0.79 (p < 0.001). The present findings revealed that the glycosylated hemoglobins reflect the time-averaged blood glucose levels in diabetics for during approximately the proceeding 3 months, indicating the usefulness of measuring the glycosylated hemoglobins in assessing the long-term blood glucose control in diabetics.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6780328     DOI: 10.1507/endocrj1954.27.411

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  3 in total

1.  Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.

Authors:  R L Garlick; J S Mazer; P J Higgins; H F Bunn
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

2.  HbA1c method evaluation for postmortem samples.

Authors:  Terhi Keltanen; Antti Sajantila; Tiina Valonen; Teija Partanen; Katarina Lindroos
Journal:  Forensic Sci Med Pathol       Date:  2014-12-24       Impact factor: 2.007

3.  Glycated haemoglobin (HbA1c) for postmortem diagnosis of diabetes.

Authors:  Delia Lepik; Mailis Tõnisson; Anne Kuudeberg; Marika Väli
Journal:  Forensic Sci Res       Date:  2018-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.